High Output Stoma Clinical Trial
Official title:
Evaluation of Lanreotide Efficacity in High Output Stoma: a Multicentric Randomized Study
Dehydration is a major problem of high output stoma with a 17% rate of readmission at 30
days. Dehydratations are resulting of significant electrolyte loss: sodium, potassium and
renal failure. Nowadays, there are no recommendations nor national nor international for high
output ileostomy treatment. Apart from the anti-diarrhea treatments used in current practice,
somatostatin analogs have proven efficacy in the literature. Theses analogs permit to
decrease significantly gastrointestinal secretions. Several teams use these analogs in order
to decrease the flow of highly productive ileostomy.
The aim of the study is to evaluate the efficacy first line treatment with lanreotide
associated with current anti-diarrheal treatment for patients with high output ileostomy (or
greater throughput 1.5l / 24h) with or without associated dehydration
n/a